Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Pitchot

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Journal of Affective Disorders|July 2, 2013
Extended-release quetiapine fumarate (quetiapine XR) monotherapy and quetiapine XR or lithium as add-on to antidepressants in patients with treatment-resistant major depressive disorderMichael Bauer, Liliana Dell'osso, Siegfried Kasper, et al.
Journal of Psychopharmacology (Oxford, England)|January 13, 2012
The hidden third: improving outcome in treatment-resistant depressionThomas E Schlaepfer, Hans Agren, Palmiero Monteleone, et al.
Journal of Psychopharmacology (Oxford, England)|September 24, 2011
Second generation antipsychotics in the treatment of bipolar depression: a systematic review and meta-analysisJürgen De Fruyt, Ellen Deschepper, Kurt Audenaert, et al.
Current Medical Research and Opinion|October 22, 2011
Aripiprazole in patients with bipolar mania and beyond: an update of practical guidanceGuy M Goodwin, Mocrane Abbar, Thomas E Schlaepfer, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|December 24, 2014
What to expect from a third step in treatment resistant depression: A prospective open study on escitalopramDaniel Souery, Raffaella Calati, Konstantinos Papageorgiou, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Journal of Affective Disorders|July 2, 2013
Extended-release quetiapine fumarate (quetiapine XR) monotherapy and quetiapine XR or lithium as add-on to antidepressants in patients with treatment-resistant major depressive disorderMichael Bauer, Liliana Dell'osso, Siegfried Kasper, et al.
Journal of Psychopharmacology (Oxford, England)|January 13, 2012
The hidden third: improving outcome in treatment-resistant depressionThomas E Schlaepfer, Hans Agren, Palmiero Monteleone, et al.
Journal of Psychopharmacology (Oxford, England)|September 24, 2011
Second generation antipsychotics in the treatment of bipolar depression: a systematic review and meta-analysisJürgen De Fruyt, Ellen Deschepper, Kurt Audenaert, et al.
Current Medical Research and Opinion|October 22, 2011
Aripiprazole in patients with bipolar mania and beyond: an update of practical guidanceGuy M Goodwin, Mocrane Abbar, Thomas E Schlaepfer, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|December 24, 2014
What to expect from a third step in treatment resistant depression: A prospective open study on escitalopramDaniel Souery, Raffaella Calati, Konstantinos Papageorgiou, et al.
Pageof 2